Ticker
GTBPCompany Name
GT BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Dividends & Other Cash Distributions | Payout Yield |
---|---|---|---|---|
6/30/2025 | $ 5.16M | $ 1.05M | $ 0 | -20.39% |
3/31/2025 | $ 5.79M | $ 3.59M | $ 0 | -62% |
12/31/2024 | $ 4.8M | $ 2.98M | $ 0 | -61.95% |
9/30/2024 | $ 6.73M | $ 2.98M | $ 0 | -44.25% |
6/30/2024 | $ 5.12M | $ 2.98M | $ 0 | -58.16% |
3/31/2024 | $ 4.32M | $ 0 | $ 0 | 0% |
12/31/2023 | $ 6.07M | $ 6.27M | $ 0 | -103.18% |
9/30/2023 | $ 10.35M | $ 6.27M | $ 0 | -60.53% |
6/30/2023 | $ 11.38M | $ 6.27M | $ 0 | -55.08% |
3/31/2023 | $ 11.22M | $ 6.27M | $ 0 | -55.85% |
(-1 * CF - Equity -1 * CF - Dividends) / Market Cap
(=) Payout Yield
Payout Yield for GT BIOPHARMA INC is calculated as follows: (-1 * CF - Equity [ $ 0 ] -1 * CF - Dividends [ $ 0 ]) / Market Cap [ $ 14.32M ]
(=) Payout Yield [ 0% ]
Minimum
Dec 31, 2023
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.53K |
---|---|
min | -15.69% |
max | 16.92% |
average | 1.82% |
median | 1.33% |
std | 5.11% |